Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
Bioanalysis|June 8, 2021
Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patientsConstance Delaby, Jérôme Vialaret, Christophe Hirtz, et al.
Bioanalysis|February 22, 2017
Comparison of HbA1c detection in whole blood and dried blood spots using an automated ion-exchange HPLC systemAleksandra Maleska, Christophe Hirtz, Elise Casteleyn, et al.
Clinical Chemistry and Laboratory Medicine|February 27, 2015
Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applicationsPauline Bros, Vincent Delatour, Jérôme Vialaret, et al.
Rapid Communications in Mass Spectrometry : RCM|September 29, 2015
Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolismSylvain Lehmann, Jérôme Vialaret, Guillaume Gras Combe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 7, 2016
Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?Sylvain Lehmann, Cato Brede, Pierre Lescuyer, et al.
Critical Reviews in Clinical Laboratory Sciences|May 25, 2018
Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methodsChristophe Hirtz, Pauline Bros, Cato Brede, et al.
Brain Communications|November 18, 2024
Glial fibrillary acidic protein in Alzheimer's disease: a narrative reviewFlorine Leipp, Jérôme Vialaret, Pablo Mohaupt, et al.
Journal of Alzheimer'S Disease : JAD|July 25, 2018
Alzheimer's Disease: Advances in Drug DevelopmentMorgane Piton, Christophe Hirtz, Caroline Desmetz, et al.
Neurobiology of Aging|February 26, 2017
Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer processAudrey Gabelle, Isabelle Jaussent, Christophe Hirtz, et al.
Alzheimer'S Research & Therapy|March 19, 2020
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identificationNicolas R Barthélemy, Randall J Bateman, Christophe Hirtz, et al.
Pageof 15